The coronary haemodynamic effect of atenolol, a new cardioselective beta-adrenergic blocker, was studied in 15 patients with angina pectoris.
The coronary haemodynamic effect of atenolol, a new cardioselective beta-adrenergic blocker, was studied in 15 patients with angina pectoris.
Myocardial blood flow from the anterolateral part of the left ventricle was measured by the continuous infusion thermodilution method by means of a two-thermistor catheter with pacing electrodes placed in the great cardiac vein. Catheters were also positioned in the pulmonary artery and the thoracic aorta for blood sampling, pressure measurements, and cardiac output determination. Investigations were performed at rest, at slow, and at submaximal atrial pacing rates before and 10 minutes after injection of 5 mg atenolol intravenously. Coronary angiography was performed in all patients.
Atenolol reduced resting myocardial blood flow by 16 per cent (P<0-001) and oxygen consumption by 17 per cent (P<0-001). Flow was reduced whether or not the part of myocardium in question was supplied by a stenotic artery. Coronary arteriolar resistance increased by 23 per cent (P<0 001). Myocardial arteriovenous oxygen difference was not affected. Heart rate and rate-pressure index were reduced in all patients (P<0-001). When the heart rate was kept constant by atrial pacing there was no change in the rate-pressure index and no change in any of the coronary haemodynamic values. A small but highly significant increase of 2 mmHg± 0*4 (SEM) in left ventricularfilling pressure was observed at rest (P<0-001), and 4 mmHg± 07 (P=0-001) during submaximal pacing. In all three situations theflow per unit left ventricular pressure work was identical before and after atenolol.
It is concluded that the decrement in myocardial bloodflow and oxygen consumption effected by the drug could be attributed solely to the reduction in left ventricular work. No direct effect on coronary resistance could be identified. By reducing left ventricular work atenolol will be effective in the treatment of ischaemic heart disease. Since it increases left ventricular filling pressure it must be used with care in patients with latent heart failure. (Barrett et al., 1973) .
Clinical studies in patients with ischaemic heart disease have shown that atenolol reduces significantly the frequency of anginal attacks (Roy et 
MEASUREMENTS
Cardiac venous flow was measured by the continuous infusion thermodilution method (Ganz et al., 1971) . For this purpose a 0 9 per cent saline solution at room temperature was infused into the great cardiac vein with a Harvard infusion pump at a constant rate of 36 ml/min for 20 to 30 seconds. This method has been found to be reliable for determination of great cardiac venous blood flow in our laboratory with a mean difference between duplicate measurements performed within 1 minute of 3-6 per cent of mean flow (Simonsen, 1977 Statistical analysis was performed using standard procedures. Student's t test for paired comparison was used when observations before were compared with those after atenolol. Differences were regarded as significant when P < 0 05.
Results
The effect ofatenolol on coronary haemodynamics is presented in Table 1 and that on general haemodynamics in Table 2. OBSERVATIONS AT REST A reduction in great cardiac venous blood flow (19) 58 ( (3) 82 (2) 110 ( in flow, myocardial oxygen consumption, coronary arteriolar resistance, heart rate, and rate pressure index for all the patients are graphically presented in Fig. 1 to 5. The diastolic pulmonary arterial pressure showed a mean increase of 2 mmHg +04. Though numerically small the increase was consistent (Fig. 6 ) and statistically significant (P < 0.001). The increase is, in the absence of mitral valvular disease, taken to represent an increase in left ventricular block after administration of the drug. He was, therefore, excluded from all calculations affected by this feature. Systolic aortic pressure, cardiac output, and the derived values for cardiac work, ratepressure index, and left ventricular minute work, were not significantly altered. However, as at rest, there was a small but highly significant increase in diastolic pulmonary arterial pressure. At the slow pacing the increase was 2 mmHg ±06 (SEM) (P < 0-001) and at the submaximal pacing 4 mmHg +0 7 (P=0 001). The relation between myocardial blood flow (and oxygen consumption) and left ventricular work was unchanged by atenolol.
Discussion
The present study has shown a reduction in myocardial blood flow and oxygen consumption and an increased coronary arteriolar resistance after atenolol. This supports previous work describing a reduction in flow after application of other selective (Moccetti et al., 1972) as well as non-selective betaadrenergic blockers (Wolfson et al., 1966; Stein et al., 1968; Mueller et al., 1974) . However, the opposite effect has also been described (Bussmann et al., 1970) .
The explanation for these findings must be sought among effects on determinants of myocardial oxygen consumption and possible direct effects on the coronary arteries.
The myocardial oxygen consumption at rest was reduced by atenolol parallel to a reduction in heart rate. By keeping the heart rate constant before and after the drug a stable haemodynamic state was achieved. There was no significant change in systolic aortic pressure and, therefore, the ratepressure index remained unaltered. Thus, one of the main determinants of myocardial oxygen demand (J0rgensen et al., 1973; Nelson et al., 1974) was constant and oxygen consumption and myocardial blood flow remained unchanged. Considering blood flow and oxygen consumption per unit left ventricular work there was no change after atenolol in any of the 3 experimental situations. This shows that the mechanism responsible for the diminished blood flow at rest was probably a reduction in left ventricular work. Since the metabolic requirements of the myocardium were reduced, myocardial blood flow fell proportionately. This is in agreement with what has been previously shown for other beta-blockers in animal experiments (Stein et al., 1968; Marchetti et al., 1972) and in man (Wolfson and Gorlin, 1969) . When, however, as shown in the present study, the work is increased again to pretreatment levels the flow increases in proportion.
The coronary arteriolar resistance at rest increased significantly after atenolol. The reduced flow could, therefore, be explained by an inhibition of sympathetic vasodilator tone as suggested for other beta-blockers (Klocke et al., 1965; Parratt and Grayson, 1966) . If this is a primary effect of the drug one would expect increased coronary arteriolar resistance and decreased flow also when myocardial oxygen demand is kept at the same level as before the beta-blockade. No change occurred after selective beta-blockade with atenolol under these circumstances. It has also been shown that the coronary arteries of the dog dilate to the same extent in response to temporary coronary occlusion before and after non-selective beta-blockade (Marchetti et al., 1972 ). The present study shows that atenolol does not affect the ability of the human coronary arteries to dilate in response to an increase in myocardial oxygen demand. This is so both at low and submaximal levels of left ventricular work, and confirms an earlier study (Stephens et al., 1976) in which atenolol was found not to give rise to coronary vasoconstriction. It has been shown (Pitt and Craven, 1970) that beta-blockade with propranolol alters the distribution of intramyocardial blood flow in the dog so that flow is selectively reduced to non-ischaemic areas. Other workers (Wolfson and Gorlin, 1969) have suggested that the action of propranolol in man may result in a more equitable distribution of coronary flow. This was assumed to occur if collateral vessels supplying ischaemic zones arose proximal to the arteriolar resistance bed and did not contain adrenergic receptors. Collaterals would then be given a selective advantage regarding perfusion when undiseased arterioles were constricted because of unopposed alpha effect after beta-blockade. The great cardiac vein drains the anterolateral left ventricular wall and the anterior part of the interventricular septum, in general the same area which gets its arterial supply through the left anterior descending artery. In the present study blood flow was reduced whether or not there was stenosis on this artery. There was, however, a smaller reduction in flow from the myocardium supplied by a stenotic artery. Flow per unit work was, however, equal in the two groups of patients.
The smaller reduction in rate pressure index in the patients with left anterior descending artery stenosis seems, therefore, to be the most likely explanation for the difference in flow observed.
The increase in pulmonary arterial diastolic pressure after atenolol is presumed to reflect an increased left ventricular filling pressure. The drug may, therefore, increase ventricular wall tension and the diastolic volume of the heart as has been shown for other beta-blockers (Chamberlain, 1966; Swanton et al., 1976) and thus increase myocardial oxygen demand (Simaan, 1974) which would tend to increase myocardial blood flow. Myocardial contractility was not measured in the present investigation, but has been shown to be decreased after atenolol (Stephan et al., 1976) and this reduces oxygen consumption. These effects are small and probably balance one another since there is in all investigations a close relation between flow and pressure work.
The reduction in determinants of myocardial oxygen consumption seen in the present study after atenolol has also been seen during physical exercise (Astr0m and Vallin, 1974) . This explains why it is an effective antianginal drug. The effect on the left ventricular filling pressure indicates, however, that in common with all beta-adrenergic blocking agents, it must be used with care in patients with latent heart failure.
